Suppr超能文献

腺苷脱氨酶作用于 RNA(ADARs)与病毒感染。

Adenosine Deaminases Acting on RNA (ADARs) and Viral Infections.

机构信息

Division of Veterinary Medicine, Paul-Ehrlich-Institute, Langen 63225, Germany.

Department of Molecular, Cellular, and Developmental Biology, University of California, Santa Barbara, California 93106, USA; email:

出版信息

Annu Rev Virol. 2021 Sep 29;8(1):239-264. doi: 10.1146/annurev-virology-091919-065320. Epub 2021 Apr 21.

Abstract

C6 deamination of adenosine (A) to inosine (I) in double-stranded RNA (dsRNA) is catalyzed by a family of enzymes known as ADARs (adenosine deaminases acting on RNA) encoded by three genes in mammals. Alternative promoters and splicing produce two ADAR1 proteins, an interferon-inducible cytoplasmic p150 and a constitutively expressed p110 that like ADAR2 is a nuclear enzyme. ADAR3 lacks deaminase activity. A-to-I editing occurs with both viral and cellular RNAs. Deamination activity is dependent on dsRNA substrate structure and regulatory RNA-binding proteins and ranges from highly site selective with hepatitis D RNA and glutamate receptor precursor messenger RNA (pre-mRNA) to hyperediting of measles virus and polyomavirus transcripts and cellular inverted elements. Because I base-pairs as guanosine instead of A, editing can alter mRNA decoding, pre-mRNA splicing, and microRNA silencing. Editing also alters dsRNA structure, thereby suppressing innate immune responses including interferon production and action.

摘要

腺嘌呤(A)在双链 RNA(dsRNA)中向肌苷(I)的 C6 脱氨作用是由一类称为 ADARs(作用于 RNA 的腺苷脱氨酶)的酶催化的,这些酶由哺乳动物的三个基因编码。不同的启动子和剪接产生两种 ADAR1 蛋白,一种是干扰素诱导的细胞质 p150,另一种是组成型表达的 p110,与 ADAR2 一样,它是一种核酶。ADAR3 缺乏脱氨酶活性。A 到 I 的编辑发生在病毒和细胞 RNA 上。脱氨活性依赖于 dsRNA 底物结构和调节 RNA 结合蛋白,范围从高度位点选择性的肝炎 D RNA 和谷氨酸受体前体信使 RNA(pre-mRNA)到麻疹病毒和多瘤病毒转录物和细胞反向元件的超编辑。因为 I 碱基与鸟嘌呤配对而不是 A,编辑可以改变 mRNA 解码、pre-mRNA 剪接和 microRNA 沉默。编辑还改变 dsRNA 结构,从而抑制包括干扰素产生和作用在内的先天免疫反应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验